A government committee in India is expected to submit a report this week recommending that the country scrutinize pharmaceutical mergers and perhaps make it harder for foreign investors to acquire drug makers.
WSJ.com: What's News US, Wall Street Journal
Mon, 09/26/2011 - 10:07am
A government committee in India is expected to submit a report this week recommending that the country scrutinize pharmaceutical mergers and perhaps make it harder for foreign investors to acquire drug makers.